Brian Adams
2017 - Keryx Biopharmaceuticals
In 2017, Brian Adams earned a total compensation of $1.2M as Former General Counsel and Secretary at Keryx Biopharmaceuticals, a 27% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $139,730 |
|---|---|
| Option Awards | $386,042 |
| Salary | $366,988 |
| Stock Awards | $269,588 |
| Other | $5,672 |
| Total | $1,168,020 |
Adams received $386K in option awards, accounting for 33% of the total pay in 2017.
Adams also received $139.7K in non-equity incentive plan, $367K in salary, $269.6K in stock awards and $5.7K in other compensation.
Rankings
In 2017, Brian Adams' compensation ranked 8,227th out of 14,666 executives tracked by ExecPay. In other words, Adams earned more than 43.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,227 out of 14,666 | 44th |
Division Manufacturing | 3,106 out of 5,768 | 46th |
Major group Chemicals And Allied Products | 1,021 out of 2,074 | 51st |
Industry group Drugs | 803 out of 1,730 | 54th |
Industry Pharmaceutical Preparations | 629 out of 1,329 | 53rd |
Source: SEC filing on May 31, 2018.
Adams' colleagues
We found four more compensation records of executives who worked with Brian Adams at Keryx Biopharmaceuticals in 2017.